Dr. Hans C. Andersson, MD

Dr. Andersson practices at Manning Family Children's in New Orleans, Louisiana, part of LCMC Health.

Dr. Andersson's NPI, 1801987664, was assigned on September 27, 2006. Dr. Andersson graduated from Tulane University School of Medicine in 1984. Dr. Andersson's Louisiana license number on file is 017892.

Dr. Andersson's primary practice is Manning Family Children's, at 200 Henry Clay Ave, New Orleans, LA 70118 in Orleans Parish. The practice phone is (504) 899-9511.

Dr. Andersson's primary practice is Manning Family Children's in New Orleans, Louisiana, part of LCMC Health. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Andersson to 5 more group practices and clinics and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andersson practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Andersson's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Andersson is board certified in clinical biochemical/molecular genetics by the American Board of Medical Genetics and Genomics. Dr. Andersson has a license on file in Louisiana.

Across all payers, Dmand AI patient panel data puts Dr. Andersson's median patient age at 10, with 47% women.

In 2024, Dr. Andersson wrote 63 Medicare Part D claims. 52% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $2,470,087 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

Dr. Andersson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 50 papers to Dr. Andersson, published from 2005 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Gaucher Disease, Glucosylceramidase and Developmental Disabilities. Dr. Andersson has published most often in Genet Med. Dr. Andersson's most frequent co-authors are Paige B. Kaplan, MD, Barry E. Rosenbloom, MD and Neal J. Weinreb, MD.

Dmand AI links Dr. Andersson to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Congenital Disorders of Glycosylation, Phenylketonurias and Amino Acid Metabolism, Inborn Errors.

CMS Open Payments shows 144 general payments to Dr. Andersson from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Sanofi and Genzyme US Companies paid the most, $30,091.

Dmand AI lists 3 awards for Dr. Andersson, most recently America's Top Doctors in 2021. Dr. Andersson serves on Molecular Genetics Pathology 2012-2017 Accreditation Council of Graduate Medical Education.

Dr. Andersson graduated from Tulane University School of Medicine in 1984. Dr. Andersson is a member of American College of Medical Genetics and Genomics, Society for Pediatric Research and Society of Inherited Metabolic Diseases.

Dr. Andersson is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.